US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist
  • 25.3800
  • +1.1300+4.66%
Close Dec 13 16:00 ET
  • 25.3800
  • 0.00000.00%
Post 20:01 ET
133.95MMarket Cap-12.82P/E (TTM)

Monopar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-29.13%6.02M
-30.15%7.12M
-24.69%8.79M
-44.62%7.27M
-44.62%7.27M
-40.66%8.49M
-38.10%10.19M
-34.47%11.68M
-35.38%13.12M
-35.38%13.12M
-Cash and cash equivalents
9.15%6.02M
-15.17%6.12M
36.36%7.81M
-11.24%7.27M
-11.24%7.27M
-61.48%5.52M
-56.18%7.21M
-67.87%5.73M
-59.68%8.19M
-59.68%8.19M
-Short-term investments
----
-66.44%998.84K
-83.43%985.73K
--0
--0
--2.98M
--2.98M
--5.95M
--4.93M
--4.93M
Other current assets
-32.27%49.57K
-44.46%61.02K
11.39%118.99K
44.48%66.43K
44.48%66.43K
31.41%73.19K
-41.92%109.87K
-44.83%106.82K
-78.88%45.98K
-78.88%45.98K
Total current assets
-29.16%6.07M
-30.30%7.18M
-24.36%8.91M
-44.31%7.33M
-44.31%7.33M
-40.38%8.57M
-38.14%10.3M
-34.58%11.78M
-35.84%13.17M
-35.84%13.17M
Non current assets
Net PPE
--0
--0
--0
-79.35%12.65K
-79.35%12.65K
-65.58%25.09K
-55.75%37.33K
-8.04%49.38K
--61.23K
--61.23K
-Gross PPE
--0
--0
--0
-79.35%12.65K
-79.35%12.65K
-65.58%25.09K
-55.75%37.33K
-8.04%49.38K
--61.23K
--61.23K
Total non current assets
--0
--0
--0
-79.35%12.65K
-79.35%12.65K
-65.58%25.09K
-55.75%37.33K
-8.04%49.38K
--61.23K
--61.23K
Total assets
-29.37%6.07M
-30.55%7.18M
-24.68%8.91M
-44.47%7.35M
-44.47%7.35M
-40.51%8.59M
-38.23%10.34M
-34.51%11.83M
-35.55%13.23M
-35.55%13.23M
Liabilities
Current liabilities
Current liabilities
-43.34%1.12M
-56.45%1.09M
-50.30%1.44M
-43.83%1.76M
-43.83%1.76M
3.53%1.98M
14.40%2.5M
168.85%2.89M
97.96%3.13M
97.96%3.13M
Non current liabilities
Long term debt and capital lease obligation
----
----
----
--0
--0
--0
--0
--0
--8.41K
--8.41K
-Long term capital lease obligation
----
----
----
--0
--0
--0
--0
--0
--8.41K
--8.41K
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--8.41K
--8.41K
Total liabilities
-43.34%1.12M
-56.45%1.09M
-50.30%1.44M
-43.98%1.76M
-43.98%1.76M
2.41%1.98M
12.69%2.5M
162.65%2.89M
98.50%3.14M
98.50%3.14M
Shareholders'equity
Share capital
-75.17%3.53K
26.65%17.6K
32.23%17.48K
15.12%14.91K
15.12%14.91K
10.44%14.2K
9.42%13.9K
4.76%13.22K
2.77%12.95K
2.77%12.95K
-common stock
-75.17%3.53K
26.65%17.6K
32.23%17.48K
15.12%14.91K
15.12%14.91K
10.44%14.2K
9.42%13.9K
4.76%13.22K
2.77%12.95K
2.77%12.95K
Retained earnings
-11.09%-64.87M
-12.62%-63.56M
-14.03%-61.85M
-16.22%-60.21M
-16.22%-60.21M
-19.39%-58.39M
-21.35%-56.44M
-23.99%-54.24M
-25.47%-51.8M
-25.47%-51.8M
Paid-in capital
7.44%69.82M
8.36%69.63M
9.76%69.3M
6.34%65.79M
6.34%65.79M
5.91%64.99M
5.34%64.25M
4.01%63.14M
2.74%61.87M
2.74%61.87M
Gains losses not affecting retained earnings
-378.32%-10.99K
14.35%8.26K
-86.69%4.23K
-258.04%-14.13K
-258.04%-14.13K
-90.81%3.95K
-58.65%7.22K
949.01%31.79K
382.97%8.94K
382.97%8.94K
Total stockholders'equity
-25.18%4.95M
-22.29%6.09M
-16.41%7.48M
-44.62%5.59M
-44.62%5.59M
-47.15%6.61M
-46.02%7.84M
-47.28%8.94M
-46.73%10.09M
-46.73%10.09M
Total equity
-25.18%4.95M
-22.29%6.09M
-16.41%7.48M
-44.62%5.59M
-44.62%5.59M
-47.15%6.61M
-46.02%7.84M
-47.28%8.94M
-46.73%10.09M
-46.73%10.09M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -29.13%6.02M-30.15%7.12M-24.69%8.79M-44.62%7.27M-44.62%7.27M-40.66%8.49M-38.10%10.19M-34.47%11.68M-35.38%13.12M-35.38%13.12M
-Cash and cash equivalents 9.15%6.02M-15.17%6.12M36.36%7.81M-11.24%7.27M-11.24%7.27M-61.48%5.52M-56.18%7.21M-67.87%5.73M-59.68%8.19M-59.68%8.19M
-Short-term investments -----66.44%998.84K-83.43%985.73K--0--0--2.98M--2.98M--5.95M--4.93M--4.93M
Other current assets -32.27%49.57K-44.46%61.02K11.39%118.99K44.48%66.43K44.48%66.43K31.41%73.19K-41.92%109.87K-44.83%106.82K-78.88%45.98K-78.88%45.98K
Total current assets -29.16%6.07M-30.30%7.18M-24.36%8.91M-44.31%7.33M-44.31%7.33M-40.38%8.57M-38.14%10.3M-34.58%11.78M-35.84%13.17M-35.84%13.17M
Non current assets
Net PPE --0--0--0-79.35%12.65K-79.35%12.65K-65.58%25.09K-55.75%37.33K-8.04%49.38K--61.23K--61.23K
-Gross PPE --0--0--0-79.35%12.65K-79.35%12.65K-65.58%25.09K-55.75%37.33K-8.04%49.38K--61.23K--61.23K
Total non current assets --0--0--0-79.35%12.65K-79.35%12.65K-65.58%25.09K-55.75%37.33K-8.04%49.38K--61.23K--61.23K
Total assets -29.37%6.07M-30.55%7.18M-24.68%8.91M-44.47%7.35M-44.47%7.35M-40.51%8.59M-38.23%10.34M-34.51%11.83M-35.55%13.23M-35.55%13.23M
Liabilities
Current liabilities
Current liabilities -43.34%1.12M-56.45%1.09M-50.30%1.44M-43.83%1.76M-43.83%1.76M3.53%1.98M14.40%2.5M168.85%2.89M97.96%3.13M97.96%3.13M
Non current liabilities
Long term debt and capital lease obligation --------------0--0--0--0--0--8.41K--8.41K
-Long term capital lease obligation --------------0--0--0--0--0--8.41K--8.41K
Total non current liabilities --0--0--0--0--0--0--0--0--8.41K--8.41K
Total liabilities -43.34%1.12M-56.45%1.09M-50.30%1.44M-43.98%1.76M-43.98%1.76M2.41%1.98M12.69%2.5M162.65%2.89M98.50%3.14M98.50%3.14M
Shareholders'equity
Share capital -75.17%3.53K26.65%17.6K32.23%17.48K15.12%14.91K15.12%14.91K10.44%14.2K9.42%13.9K4.76%13.22K2.77%12.95K2.77%12.95K
-common stock -75.17%3.53K26.65%17.6K32.23%17.48K15.12%14.91K15.12%14.91K10.44%14.2K9.42%13.9K4.76%13.22K2.77%12.95K2.77%12.95K
Retained earnings -11.09%-64.87M-12.62%-63.56M-14.03%-61.85M-16.22%-60.21M-16.22%-60.21M-19.39%-58.39M-21.35%-56.44M-23.99%-54.24M-25.47%-51.8M-25.47%-51.8M
Paid-in capital 7.44%69.82M8.36%69.63M9.76%69.3M6.34%65.79M6.34%65.79M5.91%64.99M5.34%64.25M4.01%63.14M2.74%61.87M2.74%61.87M
Gains losses not affecting retained earnings -378.32%-10.99K14.35%8.26K-86.69%4.23K-258.04%-14.13K-258.04%-14.13K-90.81%3.95K-58.65%7.22K949.01%31.79K382.97%8.94K382.97%8.94K
Total stockholders'equity -25.18%4.95M-22.29%6.09M-16.41%7.48M-44.62%5.59M-44.62%5.59M-47.15%6.61M-46.02%7.84M-47.28%8.94M-46.73%10.09M-46.73%10.09M
Total equity -25.18%4.95M-22.29%6.09M-16.41%7.48M-44.62%5.59M-44.62%5.59M-47.15%6.61M-46.02%7.84M-47.28%8.94M-46.73%10.09M-46.73%10.09M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List